butyric acid has been researched along with Glioma in 22 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the function of anti-proliferative effects of HDAC inhibitors, N-butyric acid and trichostatin A, on human malignant glioma cell lines, U251-MG and D54." | 7.73 | Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. ( Aoki, H; Endo, S; Kanzawa, T; Komata, T; Kon, T; Kondo, S; Nashimoto, T; Takahashi, H; Tanaka, R, 2005) |
| " Resveratrol (Rsv) and quercetin (Quer), two natural polyphenols, are able to induce senescence in different cancer models, including gliomas, the most common and aggressive primary brain tumor." | 3.80 | Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells. ( Bonatto, D; Filippi-Chiela, EC; Kipper, FC; Lenz, G; Suhre, T; Vargas, JE, 2014) |
| " In this study, we investigated the function of anti-proliferative effects of HDAC inhibitors, N-butyric acid and trichostatin A, on human malignant glioma cell lines, U251-MG and D54." | 3.73 | Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. ( Aoki, H; Endo, S; Kanzawa, T; Komata, T; Kon, T; Kondo, S; Nashimoto, T; Takahashi, H; Tanaka, R, 2005) |
| " There was a striking similarity in the dose-response of butyrate for increasing receptor levels and inhibiting histone deacetylation." | 1.27 | Modulation of thyroid hormone nuclear receptors by short-chain fatty acids in glial C6 cells. Role of histone acetylation. ( Aranda, A; Montiel, F; Ortiz-Caro, J; Pascual, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (40.91) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Wagner, W | 1 |
| Sobierajska, K | 1 |
| Kania, KD | 1 |
| Paradowska, E | 1 |
| Ciszewski, WM | 1 |
| Qin, X | 1 |
| Xu, Y | 1 |
| Peng, S | 1 |
| Qian, S | 1 |
| Zhang, X | 1 |
| Shen, S | 1 |
| Yang, J | 1 |
| Ye, J | 1 |
| Vargas, JE | 1 |
| Filippi-Chiela, EC | 1 |
| Suhre, T | 1 |
| Kipper, FC | 1 |
| Bonatto, D | 1 |
| Lenz, G | 1 |
| Komata, T | 1 |
| Kanzawa, T | 1 |
| Nashimoto, T | 1 |
| Aoki, H | 1 |
| Endo, S | 1 |
| Kon, T | 1 |
| Takahashi, H | 1 |
| Kondo, S | 1 |
| Tanaka, R | 1 |
| Kim, EH | 1 |
| Kim, HS | 1 |
| Kim, SU | 1 |
| Noh, EJ | 1 |
| Lee, JS | 1 |
| Choi, KS | 1 |
| Entin-Meer, M | 1 |
| Rephaeli, A | 1 |
| Yang, X | 1 |
| Nudelman, A | 1 |
| VandenBerg, SR | 1 |
| Haas-Kogan, DA | 1 |
| Tang, SJ | 1 |
| Huang, YM | 1 |
| Wang, FF | 1 |
| Ebert, PS | 1 |
| Salcman, M | 1 |
| Haag, MM | 1 |
| Krystosek, A | 1 |
| Arenson, E | 1 |
| Puck, TT | 1 |
| Sun, SH | 2 |
| Ou, HC | 2 |
| Jang, TH | 1 |
| Lin, LB | 1 |
| Huang, HM | 1 |
| Jea-Chien, E | 1 |
| Hurst, RD | 1 |
| Clark, JB | 1 |
| Yusta, B | 3 |
| Ortiz-Caro, J | 3 |
| Bedo, G | 1 |
| Pascual, A | 4 |
| Aranda, A | 4 |
| Iavarone, A | 1 |
| Eboli, ML | 1 |
| Osti, M | 1 |
| Redler, A | 1 |
| Pocchiari, M | 1 |
| Russo, MA | 1 |
| Hargreaves, AJ | 1 |
| Avila, J | 1 |
| Hesketh, JE | 1 |
| Hirschfeld, A | 1 |
| Bressler, J | 1 |
| Pennypacker, KR | 1 |
| Kyritsis, A | 1 |
| Chader, GJ | 1 |
| Billingsley, ML | 1 |
| Gross, JL | 1 |
| Behrens, DL | 1 |
| Mullins, DE | 1 |
| Kornblith, PL | 1 |
| Dexter, DL | 1 |
| Hong, SJ | 1 |
| Ko, LW | 1 |
| Montiel, F | 2 |
| Villa, A | 1 |
| Lin, LI | 1 |
| Lin, JK | 1 |
22 other studies available for butyric acid and Glioma
| Article | Year |
|---|---|
Lactate Suppresses Retroviral Transduction in Cervical Epithelial Cells through DNA-PKcs Modulation.
Topics: Benzoates; Butyric Acid; Cell Line, Tumor; Cell Nucleus; Chromones; DNA-Activated Protein Kinase; Fe | 2021 |
Sodium butyrate opens mitochondrial permeability transition pore (MPTP) to induce a proton leak in induction of cell apoptosis.
Topics: Apoptosis; Butyric Acid; Cell Line, Tumor; Glioma; Humans; Membrane Potential, Mitochondrial; Mitoch | 2020 |
Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells.
Topics: Animals; Antineoplastic Agents; Butyric Acid; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependen | 2014 |
Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells.
Topics: Apoptosis; Brain Neoplasms; Butyric Acid; Caspase 8; Caspase 9; Caspases; Cell Cycle; Cell Cycle Pro | 2005 |
Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Astrocytes; Base Sequence; Butyric Acid; CDC2 Protein Kina | 2005 |
Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas.
Topics: Antineoplastic Agents; Astrocytes; Blotting, Western; Butyric Acid; Caspases; Cell Line, Tumor; Cycl | 2005 |
Analysis of c-fos expression in the butyrate-induced F-98 glioma cell differentiation.
Topics: Animals; Base Sequence; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Gene Expressio | 1995 |
Differentiation therapy is potentiated by chemotherapy and hyperthermia in human and canine brain tumor cells in vitro.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Bucladesine; Butyrates; Butyric Acid; Carmustine; C | 1994 |
Reverse transformation and genome exposure in the C6 glial tumor cell line.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Animals, Newborn; Brain; Bucladesine; Butyrates; Bu | 1994 |
Altered phospholipid metabolism in sodium butyrate-induced differentiation of C6 glioma cells.
Topics: Acylation; Animals; Arachidonic Acid; Butyrates; Butyric Acid; Calcium; Chloroform; Glioma; Glutamat | 1997 |
Sodium butyrate decreases histamine-stimulated calcium mobilization in C6 glioma cells.
Topics: Animals; Butyrates; Butyric Acid; Calcium; Cell Differentiation; Chlorpheniramine; Fluorescent Dyes; | 1997 |
Butyric acid mediated induction of enhanced transendothelial resistance in an in vitro model blood-brain barrier system.
Topics: Blood-Brain Barrier; Butyric Acid; Cell Differentiation; Coculture Techniques; Dexamethasone; Dose-R | 1999 |
Regulation of thyroid hormone receptor and c-erbA mRNA levels by butyrate in neuroblastoma (N2A) and glioma (C6) cells.
Topics: Animals; Butyrates; Butyric Acid; Cell Division; Down-Regulation; Gene Expression Regulation, Neopla | 1990 |
3-D changes in neuroblastoma x glioma hybrid (NG 108-15) cell differentiation as studied by SEM and TEM.
Topics: Animals; Bucladesine; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Glioma; Hybrid Cells | 1989 |
Sodium butyrate induces major morphological changes in C6 glioma cells that are correlated with increased synthesis of a spectrin-like protein.
Topics: Autoradiography; Blotting, Western; Butyrates; Butyric Acid; Carrier Proteins; Electrophoresis, Poly | 1989 |
Effect of sodium butyrate on S-100 protein levels and the cAMP response.
Topics: Animals; Butyrates; Butyric Acid; Colforsin; Cyclic AMP; Glial Fibrillary Acidic Protein; Glioma; Hu | 1987 |
Calmodulin-binding proteins in human Y-79 retinoblastoma and HTB-14 glioma cell lines.
Topics: Biotin; Bucladesine; Butyrates; Butyric Acid; Calmodulin-Binding Proteins; Cell Differentiation; Cel | 1988 |
Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
Topics: Animals; Butyrates; Butyric Acid; Dose-Response Relationship, Drug; Glioma; Glycoproteins; Humans; M | 1988 |
Activation of protein expression in clonal glioma cells by sodium butyrate.
Topics: Butyrates; Butyric Acid; Cell Differentiation; Cell Division; DNA, Neoplasm; Glioma; Neoplasm Protei | 1987 |
Identification and characterization of L-triiodothyronine receptors in cells of glial and neuronal origin.
Topics: Animals; Butyrates; Butyric Acid; Cell Line; Cell Nucleus; Glioma; Kinetics; Mice; Neuroblastoma; Ne | 1986 |
Modulation of thyroid hormone nuclear receptors by short-chain fatty acids in glial C6 cells. Role of histone acetylation.
Topics: Acetates; Acetic Acid; Acetylation; Animals; Butyrates; Butyric Acid; Cell Compartmentation; Cell Nu | 1986 |
[Induction of morphological changes and polyamine alterations in glioma cells by butyrate].
Topics: Animals; Butyrates; Butyric Acid; Chromatography, High Pressure Liquid; Ethylnitrosourea; Female; Gl | 1985 |